Judicial Watch: New Documents Reveal COVID-19 Vaccine Studies Used by HHS were Conducted in China

"Judicial Watch announced today that it received 115 pages of records from the Department of Health and Human Services (HHS) revealing previously redacted locations of COVID-19 vaccine testing facilities in Shanghai, China. The Food and Drug Administration (FDA) had claimed the name and location of the testing facilities were protected by the confidential commercial information exemption of the Freedom of Information Act (FOIA).

The records were obtained through a September 2021 FOIA lawsuit filed after the FDA, the Centers for Disease Control and Prevention and the National Institute for Allergy and Infectious Disease failed to respond to a June 7, 2021, FOIA request for all biodistri [link to www.judicialwatch.org (secure)] studies and data for the COVID-19 vaccines (Judicial Watch v. U.S. Department of Health and Human Services (No. 1:21-cv-02418)).

The newly unredacted documents reveal the following Pfizer/BioNTech COVID-19 vaccine studies’ locations:

A document with the filename, “ s_r_IND 19736 0 105 2.6.5 pharmkintabulated-summary” identifies all in vitro metabolic stability studies of ALC-0315 and ALC-0159 (synthetic lipids in the vaccines) were conducted at Medicilon Preclinical Research LLC, a testing facility located in Shanghai, China.
A document with the filename, “s_r_IND 19736-0-253 Section 2.6.5 pharmkintabulated-summary” identifies that all in vitro metabolic stability studies of ALC-0315 and ALC-0159 were conducted at Medicilon Preclinical Research LLC, a testing facility located in Shanghai, China."